Hims & Hers Health is a top growth stock with strong cash flow, no debt, and an innovative AI-powered platform. Learn more on ...

was curious about the ads he saw promising to reverse his hair loss. He completed a 14-question intake on Hims.com and ...

Shares in telehealth business Hims & Hers Health (HIMS) dropped over 6% today after reports that it and peers are marketing ...

In recent years, telehealth companies like Hims and Keeps have revolutionized access to hair loss treatments by offering online consultations and direct-to-door deliveries. Their nearly ubiquitous ...

But following its start in 2017, Hims & Hers ballooned in size to become a much-watched telehealth player; in 2021, it ...

Hims & Hers Health (NYSE: HIMS) stock jumped 2.2% through 10:45 a.m. ET Monday after Morgan Stanley analyst Craig Hettenbach ...

Hims & Hers (HIMS) went all-in on weight-loss drugs. It bet big on cheaper, compounded versions of blockbuster GLP-1 treatments like ...

Hims & Hers Health's revenue grew 69% YoY, boosting its outlook. See why HIMS stock’s growth potential and high implied ...

A man has claimed his genitals 'shrank and changed shape' after taking a hair loss drug. According to the Wall Street Journal ...

was curious about the ads he saw promising to reverse his hair loss. He completed a 14-question intake on Hims.com and received a bottle of finasteride pills days later. He never spoke to a doctor.

"Hims," which advertises itself as an app for "hair loss, sexual health" and "Hers" which promotes "hair care, mental health." Morgan Stanley's research suggests the majority of downloads in ...